What is the price of the Indian version of adagrasib?

Adagrasib (Adagrasib) is a targeted treatment drug for Non-Small Cell Lung Cancer (NSCLC). It belongs to the KRAS G12C mutation inhibitor class of drugs. Adagrasiib interferes with the proliferation and growth of tumor cells by specifically inhibiting the activity of the KRAS G12C mutated gene. The drug binds to the binding pocket of KRAS protein with high affinity, thereby blocking the signaling pathway and inhibiting the proliferation of tumor cells. This targeted treatment approach for the KRAS G12C mutation is a newer area of u200bu200bresearch but has shown great promise.

The Indian version of adagrasibu belongs to the category of generic drugs. Generic drugs refer to drugs that have similar active ingredients, dosage forms, administration routes and therapeutic effects to the original adagrasibu drug. The emergence of such generic drugs aims to provide patients with treatment options that are similar to the original drugs but at a more affordable price. However, it is understood that there are currently no Indian versions of original drugs or generic drugs produced and sold. The generic drug of Adagrasibu produced by Lucius Pharmaceuticals in Laos is currently the world's first generic drug. Specifications The price of each box of 200mg*90 tablets is more than 4,000 yuan (the price may fluctuate due to the exchange rate), which is much cheaper than the original drug.

The original drug or generic drug of adagrasib is not currently on the market in China, so it cannot be included in medical insurance. Patients can only purchase adagrasib through overseas channels. The U.S. original research version Adagrasib sold overseas, Specifications200mg*180 tablets, is priced at more than 100,000 yuan per box (the price may fluctuate due to exchange rates), which is very expensive. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.